Covered recipient · General Payments record
VERNA PORTER
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$3,248.13
- Reported across 100 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $650.52 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $154.94 | 9 |
| Lilly USA, LLC | $139.83 | 6 |
| CSL Behring | $104.73 | 3 |
| ACADIA Pharmaceuticals Inc | $78.16 | 3 |
| Biogen, Inc. | $59.25 | 2 |
| Neurocrine BioSciences, Inc. | $39.42 | 1 |
| ARGENX US, INC. | $30.85 | 1 |
| EISAI INC. | $24.91 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $24.51 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147987896 | CMS |
| ACADIA Pharmaceuticals Inc | $24.00 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147987898 | CMS |
| ACADIA Pharmaceuticals Inc | $29.65 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147987900 | CMS |
| ARGENX US, INC. | $30.85 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142102610 | CMS |
| Biogen, Inc. | $27.44 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104829470 | CMS |
| Biogen, Inc. | $31.81 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104822564 | CMS |
| CSL Behring | $28.56 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134664913 | CMS |
| CSL Behring | $36.13 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134664953 | CMS |
| CSL Behring | $40.04 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134664967 | CMS |
| Eisai Inc. | $24.91 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110787089 | CMS |
| Lilly USA, LLC | $29.54 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135506356 | CMS |
| Lilly USA, LLC | $15.08 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135494342 | CMS |
| Lilly USA, LLC | $25.55 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135494344 | CMS |
| Lilly USA, LLC | $22.15 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135506360 | CMS |
| Lilly USA, LLC | $22.99 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135474640 | CMS |
| Lilly USA, LLC | $24.52 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135506358 | CMS |
| Neurocrine Biosciences, Inc. | $39.42 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150815196 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.43 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137655919 | CMS |
| UCB, Inc. | $38.23 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143063169 | CMS |
| UCB, Inc. | $15.19 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143063171 | CMS |
| UCB, Inc. | $8.04 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143063173 | CMS |
| UCB, Inc. | $18.60 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143063175 | CMS |
| UCB, Inc. | $3.80 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143063177 | CMS |
| UCB, Inc. | $7.74 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143063179 | CMS |
| UCB, Inc. | $21.94 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143063181 | CMS |
| UCB, Inc. | $7.24 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143063183 | CMS |
| UCB, Inc. | $34.16 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143063185 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.